Bioequivalence and Bioavailability Forum 17:43 CET

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Maitri
Junior

India,
2018-09-21 19:49

Posting: # 19297
Views: 722
 

 Reference Scale Average Bioequivalence Approach: ANVISA, Brazil [Regulatives / Guidelines]

Hello,

Can any one comment on acceptability of Reference Scale Bioequivalence Approach for ANVISA ( Regulatory agency of Brazil) for highly variable drugs? Do they accept RSABE study design for Highly variable drug compounds?

Thanks & Regards,
Maitri Sanghavi
d_labes
Hero

Berlin, Germany,
2018-09-22 14:11

@ Maitri
Posting: # 19298
Views: 607
 

 RSABE - ANVISA

Dear Maitri,

» Can any one comment on acceptability of Reference Scale Bioequivalence Approach for ANVISA ( Regulatory agency of Brazil) for highly variable drugs? Do they accept RSABE study design for Highly variable drug compunds?

Have you ever discovered the search field in the upper right corner of the forum?

Use it and you will find some threads dealing with the ANVISA specifications for scaled ABE. E.g. this one.

What do you think: If they have specifications for scaled ABE, do they accept studies using that approach?

Regards,

Detlew
Activity
 Thread view
Bioequivalence and Bioavailability Forum |  Admin contact
19,157 posts in 4,081 threads, 1,308 registered users;
online 5 (0 registered, 5 guests [including 3 identified bots]).

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed